Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia

Microbes and Infection

Volumn 7, Issue 2, 2005, Pages 195-203

  Ding, Kai ^a   Shibui, Akiko ^a   Wang, Yi ^a   Takamoto, Masaya ^a   Matsuguchi, Tetsuya ^b   Sugane, Kazuo ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Alveolar macrophage; Cytokine production; Pneumocystis pneumonia; Toll like receptor 4

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EMBRYO; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE SUBPOPULATION; WILD TYPE;

EID: 15244342214     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.10.010     Document Type: Article

References (51)

1. + cells in resistance to Pneumocystis carinii pneumonia in mice J. Exp. Med. 172 1990 937 945
2. J. Phair, A. Munoz, R. Detels, R. Kaslow, C. Rinaldo, and A. Saah The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1 New Engl. J. Med. 322 1990 161 165
3. F.E. Lund, K. Schuer, M. Hollifield, T.D. Randall, and B.A. Garvy Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody J. Immunol. 171 2003 1423 1430
4. A.H. Limper, J.S. Hoyte, and J.E. Standing The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung J. Clin. Invest. 99 1997 2110 2117
5. R. Hanano, K. Reifenberg, and S.H. Kaufmann Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii Infect. Immun. 66 1998 305 314
6. C. Steele, L. Marrero, S. Swain, A.G. Harmsen, M. Zheng, and G.D. Brown Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor J. Exp. Med. 198 2003 1677 1688
7. R.A. Ezekowitz, D.J. Williams, H. Koziel, M.Y. Armstrong, A. Warner, and F.F. Richards Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor Nature 351 1991 155 158
8. D.M. O'Riordan, J.E. Standing, and A.H. Limper Pneumocystis carinii glycoprotein A binds macrophage mannose receptors Infect. Immun. 63 1995 779 784
9. E.N. Atochina, A.J. Gow, J.M. Beck, A. Haczku, A. Inch, and H. Kadire Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice J. Infect. Dis. 189 2004 1528 1539
10. A.L. Laursen, N.S. Obel, U. Holmskov, J.C. Jensenius, M. Aliouat el, and P.L. Andersen Activation of the respiratory burst by Pneumocystis carinii, efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin APMIS 111 2003 405 415
11. R. Vassallo, T.J. Kottom, J.E. Standing, and A.H. Limper Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii Am. J. Respir. Cell Mol. Biol. 25 2001 203 211
12. B. Lemaitre, E. Nicolas, L. Michaut, J.M. Reichhart, and J.A. Hoffmann The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults Cell 86 1996 973 983
13. O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, and T. Ogawa Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components Immunity 11 1999 443 451
14. T.K. Means, S. Wang, E. Lien, A. Yoshimura, D.T. Golenbock, and M.J. Fenton Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis J. Immunol. 163 1999 3920 3927
15. M. Hirschfeld, C.J. Kirschning, R. Schwandner, H. Wesche, J.H. Weis, and R.M. Wooten Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2 J. Immunol. 163 1999 2382 2386
16. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 Nature 413 2001 732 738
17. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, and X. Du Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
18. F. Hayashi, K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, and D.R. Goodlett The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 2001 1099 1103
19. K. Takeda, O. Takeuchi, and S. Akira Recognition of lipopeptides by Toll-like receptors J. Endotoxin Res. 8 2002 459 463
20. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
21. A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, and C.B. Wilson The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors Proc. Natl. Acad. Sci. USA 97 2000 13766 13771
22. S. Shoham, C. Huang, J.M. Chen, D.T. Golenbock, and S.M. Levitz Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule J. Immunol. 166 2001 4620 4626
23. A. Meier, C.J. Kirschning, T. Nikolaus, H. Wagner, J. Heesemann, and F. Ebel Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages Cell. Microbiol. 5 2003 561 570
24. M.G. Netea, C.A. Van Der Graaf, A.G. Vonk, I. Verschueren, J.W. Van Der Meer, and B.J. Kullberg The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis J. Infect. Dis. 185 2002 1483 1489
25. D.-C. Eduardo, and C. Jean-Charles In vitro systems in Pneumocystis research Parasitol. Today 12 1996 245 249
26. B.A. Garvy, and A.G. Harmsen Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults Infect. Immun 64 1996 3987 3992
27. M. Takamoto, Y. Kusama, K. Takatsu, H. Nariuchi, and K. Sugane Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis Immunology 85 1995 285 291
28. J. Shellito, V.V. Suzara, W. Blumenfeld, J.M. Beck, H.J. Steger, and T.H. Ermak A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes J. Clin. Invest 85 1990 1686 1693
29. D.G. Rudmann, A.M. Preston, M.W. Moore, and J.M. Beck Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes J. Immunol 161 1998 360 366
30. R. Paine 3rd, A.M. Preston, S. Wilcoxen, H. Jin, B.B. Siu, S.B. Morris, J.A. Reed, G. Ross, J.A. Whitsett, and J.M. Beck Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice J. Immunol 164 2000 2602 2609
31. K. Saito, T. Yajima, H. Nishimura, K. Aiba, R. Ishimitsu, T. Matsuguchi, T. Fushimi, Y. Ohshima, Y. Tsukamoto, and Y. Yoshikai Soluble branched β-(1,4)glucans from Acetobacter species show strong activities to induce interleukin-12 in vitro and inhibit T-helper 2 cellular response with immunoglobulin E production in vivo J. Biol. Chem. 278 2003 38571 38578
32. S. Akashi, R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, and M. Kimoto Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages J. Immunol. 164 2000 3471 3475
33. Z.B. Huang, and E. Eden Effect of corticosteroids on IL1-β and TNF-α release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia Chest 104 1993 751 755
34. M. Yonemaru, K.E. Stephens, A. Ishizaka, H. Zheng, R.S. Hogue, and J.J. Crowley Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity J. Lab. Clin. Med. 114 1989 674 681
35. C. Gerard, C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, and A. Delvaux Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia J. Exp. Med. 177 1993 547 550
36. S. Ruan, C. Tate, J.J. Lee, T. Ritter, J.K. Kolls, and J.E. Shellito Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection Infect. Immun. 70 2002 6107 6113
37. M.H. Qureshi, A.G. Harmsen, and B.A. Garvy IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection J. Immunol. 170 2003 1002 1009
38. A. Denys, I.A. Udalova, C. Smith, L.M. Williams, C.J. Ciesielski, and J. Campbell Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages J. Immunol. 168 2002 4837 4845
39. B. Raychaudhuri, C.J. Fisher, C.F. Farver, A. Malur, J. Drazba, and M.S. Kavuru Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages Cytokine 12 2000 1348 1355
40. W.H. Dokter, S.B. Koopmans, and E. Vellenga Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-κB) which are involved in IL-6 regulation Leukemia 10 1996 1308 1316
41. C. Berlato, M.A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation J. Immunol. 168 2002 6404 6411
42. T.W. Wright, C.J. Johnston, A.G. Harmsen, and J.N. Finkelstein Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation Infect. Immun. 67 1999 3452 3460
43. P.Y. Hahn, S.E. Evans, T.J. Kottom, J.E. Standing, R.E. Pagano, and A.H. Limper Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism J. Biol. Chem. 278 2003 2043 2050
44. T.L. Benfield Clinical and experimental studies on inflammatory mediators during AIDS-associated Pneumocystis carinii pneumonia Dan. Med. Bull 50 2003 161 176
45. T.L. Benfield, R. Van Steenwijk, T.L. Nielsen, J.R. Dichter, G.Y. Lipschik, B.N. Jensen, J. Junge, J.H. Shelhamer, and J.D. Lundgren Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia Respir. Med 89 1995 285 290
46. L.M. Colletti, A. Cortis, N. Lukacs, S.L. Kunkel, M. Green, and R.M. Strieter Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat Shock 10 1998 182 191
47. L.A. O'Neill, K.A. Fitzgerald, and A.G. Bowie The Toll-IL-1 receptor adaptor family grows to five members Trends Immunol. 24 2003 286 290
48. K. Abdi IL-12: the role of p40 versus p75 Scand. J. Immunol. 56 2002 1 11
49. B. Oppmann, R. Lesley, B. Blom, J.C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, and D. Gorman Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 2000 715 725
50. B. Abel, N. Thieblemont, V.J. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice J. Immunol 169 2002 3155 3162
51. A.D. O'Brien, D.L. Rosenstreich, and B.A. Taylor Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci Nature 287 1980 440 442